ABBV
Price:
$216.63
Market Cap:
$382.74B
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2013-01-02
Stock Exchange
NYSE
Ticker
ABBV
According to AbbVie Inc.’s latest financial reports and current stock price. The company's current ROE is 68.01%. This represents a change of -147.51% compared to the average of -143.15% of the last 4 quarters.
The mean historical ROE of AbbVie Inc. over the last ten years is 29.40%. The current 68.01% ROE has changed 131.35% with respect to the historical average. Over the past ten years (40 quarters), ABBV's ROE was at its highest in in the March 2025 quarter at 90.56%. The ROE was at its lowest in in the June 2025 quarter at -512.57%.
Average
29.40%
Median
57.77%
Minimum
-129.24%
Maximum
128.66%
Discovering the peaks and valleys of AbbVie Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 174.10%
Maximum Annual ROE = 128.66%
Minimum Annual Increase = -200.45%
Minimum Annual ROE = -129.24%
| Year | ROE | Change |
|---|---|---|
| 2025 | -129.24% | -200.45% |
| 2024 | 128.66% | 174.10% |
| 2023 | 46.94% | -31.57% |
| 2022 | 68.60% | -8.42% |
| 2021 | 74.91% | 112.20% |
| 2020 | 35.30% | -136.60% |
| 2019 | -96.45% | 43.24% |
| 2018 | -67.33% | -164.64% |
| 2017 | 104.16% | -18.88% |
| 2016 | 128.41% | -1.52% |
The current ROE of AbbVie Inc. (ABBV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
15.46%
5-year avg
37.97%
10-year avg
29.40%
AbbVie Inc.’s ROE is less than Johnson & Johnson (26.26%), less than AstraZeneca PLC (22.41%), less than Novartis AG (31.54%), less than Novo Nordisk A/S (66.36%), less than Merck & Co., Inc. (17.93%), less than UnitedHealth Group Incorporated (12.40%), less than Amgen Inc. (89.41%), less than Gilead Sciences, Inc. (42.16%), less than Pfizer Inc. (8.37%), less than Sanofi (14.41%),
| Company | ROE | Market cap |
|---|---|---|
| 26.26% | $549.78B | |
| 22.41% | $271.29B | |
| 31.54% | $280.64B | |
| 66.36% | $191.93B | |
| 17.93% | $281.24B | |
| 12.40% | $364.13B | |
| 89.41% | $182.21B | |
| 42.16% | $153.66B | |
| 8.37% | $143.74B | |
| 14.41% | $101.89B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AbbVie Inc.'s ROE?
How is the ROE calculated for AbbVie Inc. (ABBV)?
What is the highest ROE for AbbVie Inc. (ABBV)?
What is the 3-year average ROE for AbbVie Inc. (ABBV)?
What is the 5-year average ROE for AbbVie Inc. (ABBV)?
How does the current ROE for AbbVie Inc. (ABBV) compare to its historical average?